Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Favorable safety and efficacy of ITI-007 against acutely exacerbated schizophrenia

May 8, 2014

Japanese researchers disclose novel agents for Alzheimer's disease

May 8, 2014

FDA approves IND for Epidiolex in Dravet syndrome

May 7, 2014

GeneSight Psychotropic test for antidepressant and antipsychotic treatment decisions expanded

May 7, 2014

Cytomedix announces data from RECOVER-Stroke study

May 7, 2014

Low-dose suvorexant safe and effective in elderly and nonelderly adults with primary insomnia

May 7, 2014

Novel P2X7 receptor antagonists designed by Lundbeck

May 7, 2014

Lundbeck receives funding to research LRRK2-based biomarkers in Parkinson's disease

May 7, 2014

Encouraging efficacy and safety results for ISIS-SMNRx in infants with type I SMA

May 7, 2014

Acorda receives complete response letter from FDA for Plumiaz

May 6, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...